The use of the Oxford classification of IgA nephropathy to predict renal survival
- PMID: 21885791
- PMCID: PMC3359557
- DOI: 10.2215/CJN.01170211
The use of the Oxford classification of IgA nephropathy to predict renal survival
Abstract
Background and objectives: A new classification for IgA nephropathy was recently proposed, namely the Oxford classification. It established specific pathologic features that predict the risk of progression of renal disease. This classification needs validation in different patient populations. We propose a retrospective study to evaluate the predictive value of the Oxford classification on renal survival defined by doubling creatinine or end-stage renal disease in patients with IgA nephropathy.
Design, setting, participants, & measurements: We included 183 patients with primary IgA nephropathy diagnosed between 1994 and 2005. Mean follow-up time was 77 months. Doubling creatinine occurred in 20% of the patients, and end-stage renal disease occurred in 16%. The biopsies were revisited to apply the Oxford classification. The influence of pathologic features on renal survival was analyzed in univariate and multivariate models.
Results: In univariate time-dependent analyses, tubular atrophy/interstitial fibrosis, segmental glomerulosclerosis, and endocapillary hypercellularity strongly impacted doubling creatinine or end-stage renal disease. On the contrary, mesangial hypercellularity was not associated with renal outcome. In the multivariate model, only estimated GFR at baseline was a risk factor, pathologic lesions having no independent influence.
Conclusions: We confirm the usefulness of the Oxford classification to establish the renal prognosis of patients with IgA nephropathy, although renal function at baseline seems to be of a greater importance than pathologic lesions.
Figures




Comment in
-
Validating the oxford classification of IgA nephropathy.Clin J Am Soc Nephrol. 2011 Oct;6(10):2335-6. doi: 10.2215/CJN.08440811. Clin J Am Soc Nephrol. 2011. PMID: 21979911 No abstract available.
Similar articles
-
Validation of the Oxford classification of IgA nephropathy.Kidney Int. 2011 Aug;80(3):310-7. doi: 10.1038/ki.2011.126. Epub 2011 May 4. Kidney Int. 2011. PMID: 21544062
-
Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.Saudi J Kidney Dis Transpl. 2020 Nov-Dec;31(6):1366-1375. doi: 10.4103/1319-2442.308348. Saudi J Kidney Dis Transpl. 2020. PMID: 33565449
-
Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.Am J Kidney Dis. 2013 Nov;62(5):891-9. doi: 10.1053/j.ajkd.2013.04.021. Epub 2013 Jun 29. Am J Kidney Dis. 2013. PMID: 23820066
-
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.Kidney Int. 2014 Oct;86(4):828-36. doi: 10.1038/ki.2014.63. Epub 2014 Apr 2. Kidney Int. 2014. PMID: 24694989 Free PMC article.
-
Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.Nephrology (Carlton). 2016 Dec;21(12):995-1002. doi: 10.1111/nep.12850. Nephrology (Carlton). 2016. PMID: 27414046 Review.
Cited by
-
The urine albumin-to-creatinine ratio is a reliable indicator for evaluating complications of chronic kidney disease and progression in IgA nephropathy in China.Clinics (Sao Paulo). 2016 May;71(5):243-50. doi: 10.6061/clinics/2016(05)01. Clinics (Sao Paulo). 2016. PMID: 27276392 Free PMC article.
-
Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria.Arch Med Sci. 2015 Apr 25;11(2):332-9. doi: 10.5114/aoms.2015.50965. Epub 2015 Apr 23. Arch Med Sci. 2015. PMID: 25995749 Free PMC article.
-
Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy.Nephrol Dial Transplant. 2014 Jan;29(1):109-18. doi: 10.1093/ndt/gft349. Epub 2013 Oct 22. Nephrol Dial Transplant. 2014. PMID: 24151019 Free PMC article.
-
Significance of immunohistochemical findings in Oxford classification of IgA nephropathy: The need for more validation studies.J Nephropathol. 2013 Jul;2(3):210-3. doi: 10.12860/JNP.2013.34. Epub 2013 Jul 1. J Nephropathol. 2013. PMID: 24475452 Free PMC article.
-
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.Kidney Int. 2015 Nov;88(5):974-89. doi: 10.1038/ki.2015.252. Epub 2015 Sep 16. Kidney Int. 2015. PMID: 26376134 Free PMC article. Review.
References
-
- D'Amico G: Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis 36: 227–237, 2000 - PubMed
-
- Laville M, Alamartine E: Treatment options for IgA nephropathy in adults: A proposal for evidence-based strategy. Nephrol Dial Transplant 19: 1947–1951, 2004 - PubMed
-
- Alamartine E, Sabatier JC, Berthoux FC: Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: Value of quantitative scoring and approach to final prognosis. Clin Nephrol 34: 45–51, 1990 - PubMed
-
- Radford MG, Jr, Donadio JV, Jr, Bergstralh EJ, Grande JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8: 199–207, 1997 - PubMed
-
- Katafuchi R, Kiyoshi Y, Oh Y, Uesugi N, Ikeda K, Yanase T, Fujimi S: Glomerular score as a prognosticator in IgA nephropathy: Its usefulness and limitation. Clin Nephrol 49: 1–8, 1998 - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous